It supports tissue repair by activating genes involved in collagen and elastin synthesis, regulating inflammatory pathways, promoting angiogenesis, and improving cellular regeneration
Patient selection criteria are not well-established, and determining which patients are most likely to benefit from these therapies requires clinical judgment based on limited evidence
However, recent studies have highlighted interactions between glutathione, GRX, and thioredoxins (TRX
Patients with Fitzpatrick IV to VI skin should treat conservatively initially with patch tests because of slightly elevated post-inflammatory hyperpigmentation risk
Choose injectable BPC-157 if: Your target is a tendon, ligament, joint, or muscle injury You need systemic anti-inflammatory or tissue repair effects Speed and reliability of delivery matter You are working within a structured peptide therapy protocol with a licensed provider Choose oral BPC-157 if: Your primary concern is gut health leaky gut, IBD, IBS, gastric ulcers You want high local GI concentrations, not systemic distribution You prefer non-invasive administration for long-term or maintenance use You are combining BPC-157 with another systemic peptide therapy Consider nasal delivery only if: Neurological applications are the clinical focus A licensed provider explicitly recommends it based on your presentation Injection is contraindicated and oral delivery is insufficient Do not choose a delivery method based on convenience alone
